Pharmacogenomics-Guided Antidepressant Therapy as a Solution to Treatment-Resistant Depression: A Systematic Review
Aims: Treatment-resistant depression (TRD), defined as failure to achieve remission despite adequate antidepressant trials, remains a pervasive clinical conundrum, linked to reduced quality of life, increased mortality, and higher healthcare costs. Pharmacogenomics-guided treatment (PGT) offers a po...
Saved in:
Main Author: | Leah Rose Alexander |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2025-06-01
|
Series: | BJPsych Open |
Online Access: | https://www.cambridge.org/core/product/identifier/S2056472425101919/type/journal_article |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Insomnia and Esketamine Add-On Therapy to Antidepressant Therapy in Patients with Treatment-Resistant Depression—A Pilot Study
by: Daniel Szawarnoga, et al.
Published: (2025-07-01) -
Clinically actionable pharmacogenomic landscape of antidepressants and antipsychotics in Qatar: a population-based cohort study
by: Dinesh Velayutham, et al.
Published: (2025-01-01) -
A retrospective study of predictive factors for effective aripiprazole augmentation of antidepressant therapy in treatment-resistant depression
by: Sugawara H, et al.
Published: (2016-05-01) -
Brain neuro-plasticity, depression, and antidepressant therapy
by: G. V. Pogosova, et al.
Published: (1970-01-01) -
Use of Antidepressant for the Treatment of Depression in CAMHS Outpatient
by: Chidimma Orji, et al.
Published: (2025-06-01)